0.8710
+0.0153
+(1.79%)
At close: January 10 at 4:00:00 PM EST
0.8530
-0.02
(-2.07%)
After hours: January 10 at 6:41:33 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-85,517.0000
-71,737.0000
-59,729.0000
-40,646.0000
-9,956.0000
Investing Cash Flow
-145.0000
-323.0000
-690.0000
-153.0000
--
Financing Cash Flow
-10.0000
71,860.0000
--
252,951.0000
5,102.0000
End Cash Position
80,097.0000
143,461.0000
142,858.0000
211,799.0000
3,405.0000
Capital Expenditure
-145.0000
-323.0000
-690.0000
-153.0000
--
Issuance of Capital Stock
--
75,058.0000
--
265,056.0000
5,116.0000
Free Cash Flow
-85,662.0000
-72,060.0000
-60,419.0000
-40,799.0000
-9,956.0000
12/31/2020 - 11/5/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EVAX Evaxion Biotech A/S
0.9000
-2.17%
TSBX Turnstone Biologics Corp.
0.4802
-11.07%
PBLA Panbela Therapeutics, Inc.
0.3700
+2.49%
PRTC PureTech Health plc
17.60
0.00%
KPTI Karyopharm Therapeutics Inc.
0.7186
+0.36%
QNRX Quoin Pharmaceuticals, Ltd.
0.6215
-0.26%
RLMD Relmada Therapeutics, Inc.
0.4124
-8.76%
XLO Xilio Therapeutics, Inc.
1.1000
-1.79%
ACET Adicet Bio, Inc.
0.9171
-4.47%
VIRX Viracta Therapeutics, Inc.
0.1860
-0.91%